Redding, California, March 23, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled, ‘Plasmapheresis Market by Product (Instruments, Disposables), Technology (Membrane Filtration, ...

The Plasmapheresis Market has been gaining notable momentum in the global healthcare sector due to the rising prevalence of ...

Conventional chemotherapy for myeloma comprises melphalan plus prednisone or a combined regimen such as vincristine, doxorubicin and dexamethasone. The response rate for these approaches is 40–60% and ...

January 21, 2011 — The American Academy of Neurology (AAN) has issued new guidelines on the use of plasmapheresis in the treatment of neurologic disorders. The guidelines provide evidence-based ...

Calendar year 2020 will be remembered for the COVID-19 pandemic, handwashing, and social distancing. As I write this, clinical trials are underway to test both therapeutics and vaccine candidates ...

Patients who received plasmapheresis for ANCA-associated vasculitis vs those who did not were more likely to have had AKI, AKI requiring dialysis, hypoxia, and respiratory failure requiring mechanical ...

Fenwal, a Fresenius Kabi company, announced today it has received 60601-1 3rd edition certification for the Aurora™ plasmapheresis system designed for collection of plasma. 60601-1 3rd edition is the ...

The Global Plasmapheresis Market is valued at USD 1.34 Billion in 2024 and is projected to attain a value of USD 2.97 Billion by 2035 at a CAGR of 7.55% during the forecast period 2025-2035, the ...

Desensitization allows successful kidney transplantation in individuals with high levels of donor-specific alloantibody (DSA). It is not known which of the two main desensitization ...